Please use this identifier to cite or link to this item:
http://hdl.handle.net/10397/88709
Title: | Antidepressant treatment and mortality risk in patients with dementia and depression : a nationwide population cohort study in Taiwan | Authors: | Su, JA Chang, CC Wang, HM Chen, KJ Yang, YH Lin, CY |
Issue Date: | 1-Jan-2019 | Source: | Therapeutic advances in chronic disease, 1 Jan 2019, v. 10, p. 1-14, https://doi.org/10.1177/2040622319853719 | Abstract: | Background: Dementia prevalence is increasing worldwide, and dementia is frequently comorbid with depression during its disease course. Additionally, safety concerns are rising regarding the prescription of psychotropic agents to patients with dementia. Thus, our study assessed the influence of prescribing antidepressants in dementia with depression on mortality risk, and the differences between classes of antidepressants. Methods: This study was a population-based retrospective cohort study that utilized the National Health Insurance (NHI) medical claims data on mental illness in Taiwan between 1998 and 2013. We identified 25,890 cases of newly diagnosed dementia with depression and divided them into two groups: antidepressant users and nonusers. All-cause mortality between the two groups and the effects of different antidepressants were analyzed. Results: Antidepressants reduced all-cause mortality in patients with dementia and depression after adjusting for all covariates. Furthermore, the effect was significant when antidepressant exposure was more than 168 cumulative defined daily dosages, and most classes of antidepressants had this protective effect. Conclusions: Antidepressant treatment showed significant protective effects in all-cause mortality for patients with dementia and depression. Most classes of antidepressants were effective, especially with longer treatment duration or higher dosage. |
Keywords: | Antidepressants Dementia Depression Longitudinal study Mortality |
Publisher: | Sage Publications | Journal: | Therapeutic advances in chronic disease | ISSN: | 2040-6223 | EISSN: | 2040-6231 | DOI: | 10.1177/2040622319853719 | Rights: | © The Author(s), 2019. Article reuse guidelines: sagepub.com/journalspermissions Creative Commons Non Commercial CC BY-NC:This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). The following publication Su, J. A., Chang, C. C., Wang, H. M., Chen, K. J., Yang, Y. H., & Lin, C. Y. (2019). Antidepressant treatment and mortality risk in patients with dementia and depression: A nationwide population cohort study in Taiwan. Therapeutic Advances In Chronic Disease, 10, 1-14 is available at https://dx.doi.org/10.1177/2040622319853719 |
Appears in Collections: | Journal/Magazine Article |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Su_Antidepressant_Treatment_Mortality.pdf | 267.92 kB | Adobe PDF | View/Open |
Page views
43
Last Week
0
0
Last month
Citations as of Apr 28, 2024
Downloads
14
Citations as of Apr 28, 2024
SCOPUSTM
Citations
16
Citations as of Apr 26, 2024
WEB OF SCIENCETM
Citations
14
Last Week
0
0
Last month
Citations as of May 2, 2024
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.